This reagent is intended for in-vitro quantitative determination of CK – MB in human serum.
Clinical Significance:
CK - MB test is a cardiac marker used to assist diagnosis of acute myocardial infarction.
| Method | Type | PackSize | Produt Type |
|---|---|---|---|
| Immunoinhibition | Liquixx | R1: 2 X 8 ml; R2: 2 x 2 ml | 120848 |
| Immunoinhibition | Powder | 5 x 2.5 ml | 120234 |